Marchesini G - Search Results

1

Hepatic steatosis in obese patients: clinical aspects and prognostic significance.

Festi D, Colecchia A, Sacco T, Bondi M, Roda E, Marchesini G. Festi D, et al. Among authors: marchesini g. Obes Rev. 2004 Feb;5(1):27-42. doi: 10.1111/j.1467-789x.2004.00126.x. Obes Rev. 2004. PMID: 14969505 Review.

2

Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?

Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G. Bugianesi E, et al. Among authors: marchesini g. Dig Liver Dis. 2004 Mar;36(3):165-73. doi: 10.1016/j.dld.2003.12.008. Dig Liver Dis. 2004. PMID: 15046183 Review.

3

Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance.

Marchesini G, Bianchi G, Rossi B, Muggeo M, Bonora E. Marchesini G, et al. Int J Obes Relat Metab Disord. 2000 May;24(5):552-8. doi: 10.1038/sj.ijo.0801195. Int J Obes Relat Metab Disord. 2000. PMID: 10849575

4

Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis.

Susca M, Grassi A, Zauli D, Volta U, Lenzi M, Marchesini G, Bianchi FB, Ballardini G. Susca M, et al. Among authors: marchesini g. Dig Liver Dis. 2001 Dec;33(9):768-77. doi: 10.1016/s1590-8658(01)80694-0. Dig Liver Dis. 2001. PMID: 11838612

5

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.

Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J. Bugianesi E, et al. Among authors: marchesini g. Hepatology. 2006 Dec;44(6):1648-55. doi: 10.1002/hep.21429. Hepatology. 2006. PMID: 17133473

6

Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistance.

Bianchi G, Marchesini G, Brunetti N, Manicardi E, Montuschi F, Chianese R, Zoli M. Bianchi G, et al. Among authors: marchesini g. Dig Liver Dis. 2003 Oct;35(10):722-7. doi: 10.1016/s1590-8658(03)00416-x. Dig Liver Dis. 2003. PMID: 14620622

7

Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.

Marchesini G, Avagnina S, Barantani EG, Ciccarone AM, Corica F, Dall'Aglio E, Dalle Grave R, Morpurgo PS, Tomasi F, Vitacolonna E. Marchesini G, et al. J Endocrinol Invest. 2005 Apr;28(4):333-9. doi: 10.1007/BF03347199. J Endocrinol Invest. 2005. PMID: 15966506

8

Review article: the treatment of fatty liver disease associated with the metabolic syndrome.

Marchesini G, Natale S, Manini R, Agostini F. Marchesini G, et al. Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:37-9. doi: 10.1111/j.1365-2036.2005.02593.x. Aliment Pharmacol Ther. 2005. PMID: 16225470 Free article. Review.

9

Nonalcoholic fatty liver disease and the metabolic syndrome.

Marchesini G, Babini M. Marchesini G, et al. Minerva Cardioangiol. 2006 Apr;54(2):229-39. Minerva Cardioangiol. 2006. PMID: 16778754 Review.

10

WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance.

Melchionda N, Forlani G, Marchesini G, Baraldi L, Natale S. Melchionda N, et al. Among authors: marchesini g. Int J Obes Relat Metab Disord. 2002 Jan;26(1):90-6. doi: 10.1038/sj.ijo.0801847. Int J Obes Relat Metab Disord. 2002. PMID: 11791152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters